Tzvi Palash
2017
In 2017, Tzvi Palash earned a total compensation of $432.8K as Chief Operating Officer at Protalix BioTherapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $117,000 |
|---|---|
| Option Awards | $18,843 |
| Salary | $220,817 |
| Other | $76,094 |
| Total | $432,754 |
Palash received $220.8K in salary, accounting for 51% of the total pay in 2017.
Palash also received $117K in bonus, $18.8K in option awards and $76.1K in other compensation.
Rankings
In 2017, Tzvi Palash's compensation ranked 12,363rd out of 14,666 executives tracked by ExecPay. In other words, Palash earned more than 15.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,363 out of 14,666 | 16th |
Division Manufacturing | 4,866 out of 5,770 | 16th |
Major group Chemicals And Allied Products | 1,781 out of 2,074 | 14th |
Industry group Drugs | 1,479 out of 1,730 | 15th |
Industry Biological Products, Except Diagnostic Substances | 272 out of 316 | 14th |
Source: SEC filing on March 6, 2018.
Palash's colleagues
We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2017.
2017
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2017
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2017
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2017
Yoseph Shaaltiel
Protalix BioTherapeutics